登录查看更多内容

Ensuring Purity with Precision: ICP-MS in Elemental Impurity Testing

Synergy Health Utrecht B.V.

"Certified to Guard your Health"

发布日期: 2024年10月18日

At Synergy Health Utrecht B.V. we understand the critical importance of detecting elemental impurities in pharmaceutical products. Our state-of-the-art Inductively Coupled Plasma Mass Spectroscopy (ICP-MS) technology allows us to deliver precise, reliable, and rapid analysis, ensuring compliance with stringent regulatory standards.

Partner with us for your elemental impurity testing needs and trust our cutting-edge lab to safeguard the quality and safety of your pharmaceutical products.?

?Elemental impurities Testing

#PharmaceuticalTesting #ElementalImpurities #ICPMS #PharmaQuality #AnalyticalChemistry #LaboratoryExcellence #SynergyHealthUtrecht

要查看或添加评论，请登录

Synergy Health Utrecht B.V.的更多文章

2024年11月22日

The Advantages of RI Detection in HPLC: A Comprehensive Overview

How Does RI Detection Work? Refractive Index (RI) detection measures changes in the refractive index of the mobile…
2024年11月21日

Testing Medical Devices: Ensuring Safety and Efficacy

At Synergy Health Utrecht, we're committed to safeguarding public health by providing comprehensive testing services…
2024年11月12日

Unmasking the Silent Threat: Ensure Product Safety with Synergy Health’s Chromogenic LAL Endotoxin Testing

In the world of pharmaceutical manufacturing, a silent threat lurks – Endotoxins. These tiny, yet potent molecules can…

2 条评论
2024年10月24日

Ensure Stability of Your Pharmaceutical Products with Synergy Health Utrecht

Stability testing is crucial to ensure your drug substance or finished formulation maintains its quality over time…

社区洞察

GMP

How do you verify GMP equipment and methods?
GMP

What are the most common pitfalls and mistakes to avoid in drug product specification development?
Manufacturing Operations

What are the best practices for aligning SOPs with FDA requirements in pharmaceutical manufacturing?
Analytical Methods Development

How do you demonstrate analytical method equivalence for post-approval changes?
Financial Management

How do transfer pricing methods impact pharmaceutical companies?
GMP

How do you find GMP guidance?
Biotechnology

You're in biopharmaceutical manufacturing with tight deadlines. How do you prioritize quality control tasks?
GMP

How do you implement new GMP technologies or processes?
Analytical Methods Development

How do you handle method transfer and comparability studies?
GMP

How do you compare GMP to ISO, ICH, and FDA quality standards?

其他会员也浏览了

ATF Sterilization Cycle

Pharmalab 1 年
EAS course on “Drug Discovery and Development Processes (for analytical chemists)”: Slide #9 - Perspectives and Trends of the Pharmaceutical Industry

Michael Dong 唐纬中 3 年
ATF Sterilization Cycle

Pharmalab 2 年
ECHA’s BPC supports the approval of nitrogen generated from ambient air as a low-risk active substance

Matthew Kane 1 年
Focus on chemical and pharmaceutical industry, professional provider of green vacuum systems

Julia Zhang 5 年
FDA Publishes Final Guidance on Classification of Co-Crystals

Amit Tailor 6 年
Pharmaceutical Legislation Update

Peter Gough 3 年
What is the impact of recent changes in FDA guidance on regulatory and intellectual property issues?

Shawn Comella 7 年
Are You Ready for USP 232/233?

Matthew Nigro 8 年

Synergy Health Utrecht B.V.的更多文章

The Advantages of RI Detection in HPLC: A Comprehensive Overview

Testing Medical Devices: Ensuring Safety and Efficacy

Unmasking the Silent Threat: Ensure Product Safety with Synergy Health’s Chromogenic LAL Endotoxin Testing

Ensure Stability of Your Pharmaceutical Products with Synergy Health Utrecht

社区洞察

其他会员也浏览了

ATF Sterilization Cycle

EAS course on “Drug Discovery and Development Processes (for analytical chemists)”: Slide #9 - Perspectives and Trends of the Pharmaceutical Industry

ATF Sterilization Cycle

ECHA’s BPC supports the approval of nitrogen generated from ambient air as a low-risk active substance

Focus on chemical and pharmaceutical industry, professional provider of green vacuum systems

FDA Publishes Final Guidance on Classification of Co-Crystals

Pharmaceutical Legislation Update

What is the impact of recent changes in FDA guidance on regulatory and intellectual property issues?

Are You Ready for USP 232/233?